Insulin resistance and type 2 diabetes suppress the HPG axis and lower testosterone and estradiol in men.

The clinical evidence strongly supports the link between insulin resistance, type 2 diabetes mellitus (T2DM), and the suppression of the hypothalamic-pituitary-gonadal (HPG) axis in men, leading to significantly lower levels of sex hormones.

Clinical evidence and hormonal impact

Research consistently demonstrates that men with T2DM and insulin resistance are at high risk for hypogonadism.

• Testosterone levels: Studies show the prevalence of hypogonadism in diabetic populations ranges from 37% to over 70%. Men with T2DM are significantly more likely to have subnormal testosterone compared to non-diabetic controls.
• Estradiol levels: While the data for estradiol is less extensive than for testosterone, evidence indicates a downward trend or dysregulation. Metabolic markers, such as high triglycerides, are causally linked to lower estradiol in men through Mendelian randomization studies.
• Pituitary response: The hormonal decline is characterized by a "hypogonadotropic" pattern, where the pituitary gland fails to increase Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) in response to low testosterone, signifying a central axis failure.

Mechanistic explanations

The suppression of the HPG axis occurs through complex metabolic signaling pathways that bridge energy status and reproductive function.

• Hypothalamic signaling: Insulin typically acts as a metabolic cue to stimulate the pulsatile release of Gonadotropin-Releasing Hormone (GnRH). In insulin-resistant states, signaling within Kiss1 (kisspeptin) neurons—which act as the "gatekeepers" of GnRH—is impaired, leading to disrupted GnRH secretion.
• Pituitary resistance: Insulin normally potentiates GnRH-induced signaling in the pituitary via Akt and ERK pathways. Resistance at the pituitary level further reduces the secretion of LH and FSH.
• Systemic factors: Chronic hyperglycemia and low-grade hypothalamic inflammation associated with T2DM contribute to the functional suppression of the axis, effectively turning down the body's internal drive to produce testosterone.

Bottom line

Insulin resistance and T2DM suppress the HPG axis by disrupting hypothalamic GnRH pulsatility and pituitary signaling, resulting in significantly lower testosterone levels and potentially reduced estradiol. For aging men, managing metabolic health is a critical component of maintaining endocrine function.